BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33098352)

  • 1. "Two wavelengths endovaginal laser system": Clinical evaluation of a new device for mild SUI and vaginal atrophy treatment.
    Mezzana P
    Dermatol Ther; 2020 Nov; 33(6):e14445. PubMed ID: 33098352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
    Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
    Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
    Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
    J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
    Cruff J; Khandwala S
    J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study.
    Pinheiro C; Costa T; Amorim de Jesus R; Campos R; Brim R; Teles A; Vilas Boas A; Lordêlo P
    BMC Womens Health; 2021 Oct; 21(1):379. PubMed ID: 34717608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
    Wallace SL; St Martin B; Lee K; Sokol ER
    Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and long-term efficacy of fractional CO
    Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
    Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
    Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.